Support Alert

Drug Safety Update: Pseudoephedrine and ephedrine

The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a drug safety update highlighting that sales restrictions introduced in 2008 continue to be successful in managing the risk of misuse of pseudoephedrine and ephedrine. The update includes a 2017 review of the impact of restrictions.

Further details of the update are available on the MHRA website.

The Society has previously issued guidance highlighting how community pharmacy staff should deal with requests for potentially suspicious purchases of these products.